December 18, 2006 17:14 ET

ORLive Presents: Gamma Knife Radiosurgery Treatment for an Acoustic Neuroma

Live Webcast: From Saint Joseph's Hospital and Marshfield Clinic: January 17, 2007 at 4:00 PM CST (22:00 UTC)

MARSHFIELD, WI -- (MARKET WIRE) -- December 18, 2006 -- Gamma Knife radiosurgery for an acoustic neuroma will be featured on the sixth webcast sponsored by Saint Joseph's Hospital and Marshfield Clinic. It is set for 4-5 p.m. CST Wednesday, January 17th on

During the webcast, Marshfield Clinic physicians on staff at Saint Joseph's Hospital will discuss the sophisticated treatment option for acoustic neuroma. The program will feature a pre-taped Gamma Knife procedure and real-time panel discussion and analysis.

Participating in the discussion will be Benjamin Lawler, MD, neurologist; Warren Olds, MD, Radiation Oncologist; John Neal, MD, Neurosurgeon; and David Loshek, PhD, Radiation Physicist.

An acoustic neuroma is a non-cancerous tissue growth that arises on the eighth cranial nerve leading from the brain to the inner ear. Acoustic neuromas usually grow slowly over a period of years. They expand in size at their site of origin and can displace normal brain tissue. The brain is not invaded by the tumor, but as it enlarges the tumor pushes the brain.

Acoustic neuromas large enough to cause hearing loss and other symptoms occur in about one person in 100,000. Most acoustic neuromas are diagnosed in patients between ages 30 and 60.

Saint Joseph's Hospital has offered stereotactic radiosurgery since 2000, when it became the first hospital in Wisconsin to offer the Leksell Gamma Knife Model C. More than 500 patients have been treated since then.

The Gamma Knife replaces the surgeon's scalpel with a single dose of gamma radiation, directed by highly sophisticated computer technology, to shrink benign or malignant brain tumors, and abnormal blood vessel formations in the brain, without harming adjacent, normal tissue. Since a surgical incision is not involved, the procedure can often be done quickly, there is no lengthy recuperation and most patients return to normal activities within one to three days.

Visit now to learn more and view a program preview. VNR

Contact Information

  • Contact:

    Alex Fraser
    Director of Marketing
    OR-Live / slp3D, Inc.
    860-953-2900 x 214
    Email Contact